tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AptarGroup’s Consistent Financial Strength and Pharma Segment Growth Drive Buy Rating
PremiumRatingsAptarGroup’s Consistent Financial Strength and Pharma Segment Growth Drive Buy Rating
22d ago
AptarGroup reports Q2 EPS $1.67, consensus $1.59
Premium
The Fly
AptarGroup reports Q2 EPS $1.67, consensus $1.59
22d ago
AptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
Premium
The Fly
AptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
22d ago
AptarGroup price target raised to $170 from $162 at Wells Fargo
PremiumThe FlyAptarGroup price target raised to $170 from $162 at Wells Fargo
4M ago
AptarGroup’s Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
Premium
Ratings
AptarGroup’s Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
4M ago
AptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
Premium
Company Announcements
AptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
4M ago
ATR Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsATR Upcoming Earnings Report: What to Expect?
4M ago
AptarGroup price target lowered to $175 from $190 at Raymond James
Premium
The Fly
AptarGroup price target lowered to $175 from $190 at Raymond James
4M ago
AptarGroup commences clinical study to validate SmartTrack platform
Premium
The Fly
AptarGroup commences clinical study to validate SmartTrack platform
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100